A Comprehensive Prognostic and Immune Analysis of Ferroptosis-Related Genes Identifies SLC7A11 as a Novel Prognostic Biomarker in Lung Adenocarcinoma

Figure 5

The correlation between SLC7A11 and clinicopathological parameters in LUAD. Sankey diagrams between SLC7A11 and (a) Smoking and (b) pTNM_stage. (c) High expression of SCL7A11 was identified in LUAD samples with phases III-IV in contrast to phases I-II.

(a)

(b)

(c)